"We were grateful for this opportunity to meet with our world-class Scientific Advisory Board," explained Paul Sheils, Chief Executive Officer of InterCure. "These are some of the worlds most distinguished experts on hypertension and the people involved in setting the guidelines and standards for the medical community to manage hypertension. It means a great deal that they support RESPeRATE as an effective treatment of hypertension."
The Scientific Advisory Board (SAB) is composed of several of the worlds most renowned opinion-leaders in the field of hypertension, including:
Henry R. Black, M.D., Head of the Preventive Medicine Department at Rush University, Chicago, IL, who served on the Executive Committee of the Sixth Joint National Committee on the Detection, Evaluation, and Treatment of Hypertension (JNC VI), served on the Executive Committee of the American Heart Association Council on High Blood Pressure Research, and was a member of the Executive Committee of the American Society of Hypertension;
Jay N. Cohn, M.D., Professor of Medicine, Cardiovascular Division, Department of Medicine at the University of Minnesota Medical School in Minneapolis, President of the Heart Failure Society of America, President of the International Society of Hypertension, past President of The American Society of Hypertension, former officer of the American Heart Association, and former chairman of the Cardiorenal Advisory Committee of the Food and Drug Administration;
Ehud Grossman, M.D., Head of the Department of Internal Medicine at the Chaim Sheba Medical